Regulatory Collaboration

 In the context of globalization and the internet economy, the medical product supply chain is becoming increasingly complex and variable. To enhance the safety and transparency of the supply chain, strengthening collaborative regulation of its various segments has become a topic of discussion. The center is dedicated to ensuring the quality and safety of medical products and protecting the health rights and interests of the public through multifaceted regulatory collaboration. 

 Strengthen the alignment with domestic and international regulations and policies to ensure that all links in the supply chain comply with legal requirements. Promote the establishment of a unified and coordinated regulatory system for the medical product supply chain to reduce risks associated with policy differences. 

Establish a medical product supply chain information platform to facilitate real-time sharing of information across all segments, promote transparency in the supply chain, and enhance data analysis and risk warning capabilities.

Conduct in-depth medical product supply chain risk assessments, collaboratively identify risk points, develop risk response measures, and enhance risk prevention and control capabilities.

Integrate domestic and international regulatory resources to create a unified regulatory effort, optimize regulatory processes, and improve regulatory efficiency.

Conduct training and education activities for personnel involved in various segments of medical products and the medical product supply chain.

Strengthen cooperation and exchange with advanced international regulatory agencies, learn from their advanced experiences, and enhance the level of medical product supply chain regulation in our country.